Advanced Cell Technology and its collaborators at OHSU report the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium produced under manufacturing conditions suitable for human clinical trials. The research shows long-term functional rescue using hESC-derived cells in both the RCS rat and Elov14 mouse, animal models of retinal degeneration and Stargardt disease, respectively.